SuperworthSpectral AI EPS MDAI
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- −$0.34
- Latest quarter, Q2 FY26
- −$0.13
- Fiscal year 2025
- −$0.30
Spectral AI's earnings per share was −$0.34 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.13.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.30 | n/a |
| FY2024 | −$0.82 | n/a |
| FY2023 | −$1.49 | n/a |
| FY2022 | n/a | n/a |
| FY2021 | $0.43 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.13 | n/a | −$0.34 | |
| Q1 FY26 | −$0.11 | −200% | −$0.52 | |
| Q4 FY25 | $0.03 | n/a | −$0.30 | |
| Q3 FY25 | −$0.13 | n/a | −$0.72 | |
| Q2 FY25 | −$0.31 | n/a | −$0.67 | |
| Q1 FY25 | $0.11 | n/a | −$0.52 | |
| Q4 FY24 | −$0.39 | n/a | −$0.82 | |
| Q3 FY24 | −$0.08 | n/a | −$0.65 | |
| Q2 FY24 | −$0.16 | n/a | −$1.34 | |
| Q1 FY24 | −$0.19 | n/a | −$1.41 | |
| Q4 FY23 | −$0.22 | −320% | −$1.49 | |
| Q3 FY23 | −$0.77 | n/a | −$1.17 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Spectral AI's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MDAISpectral AI | −$0.34 | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| Peer median | $1.47 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Spectral AI
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.